Workflow
葵花药业:全资孙公司广东葵花减资至3800万元
SFPMSFPM(SZ:002737) news flash·2025-07-30 07:42

Core Viewpoint - The company, Aihua Pharmaceutical (002737), has announced a reduction in the registered capital of its wholly-owned subsidiary, Guangdong Aihua Pharmaceutical Co., Ltd., from 43 million yuan to 38 million yuan [1] Group 1 - Guangdong Aihua has completed the capital reduction process and obtained the latest business license [1] - Guangdong Aihua was established on September 28, 2016, and is a limited liability company (wholly owned by a legal entity) [1] - The registered capital of Guangdong Aihua is now 38 million yuan, and its business scope includes wholesale [1]